|Articles|May 20, 2016
What everyone was tweeting about at ASCRS 2016
Author(s)Jolie Higazi
Here's a snapshot of what got attendees most excited at ASCRS 2016.
Advertisement
Abbott announces positive results from a pivotal
- Abbott (@AbbottNews)May 9, 2016
Abbott announced positive results from Tecnis Symfony IOL study
The company reported that the trial for the new IOL met its primary endpoints for improved near and intermediate vision.
Sponsored:
"Many people with cataracts are asking for an option that will help them perform near activities like reading, use their computers and tablets at intermediate distance, as well as see objects that are far away," said Jason Jones, MD, investigator on the study. "The data from this study showed that patients who received the Symfony lens were more likely to achieve improved intermediate and near vision, while maintaining similar distance vision compared with patients who received a standard IOL."
Congrats on the
- Kristen (@KHingenito)May 9, 2016
One surgeon left ASCRS with a MUCH nicer car than he had before
David R. Brear, MD, from Culpeper, VA won a Tesla Model S by entering into the ASCRS drawing. We don’t think he’ll mind that long drive home.
Great talk by
- Dr Daya Sharma (@DrDayaSharma)May 9, 2016
What NASA astronauts can teach us about glaucoma
During his talk, ‘Dark Side of the Moon: Intracranial Pressure in Glaucoma’ John P. Berdahl, MD, explained how astronauts returning from space hold some key clues about glaucoma, which he called a two-pressure disease. To read more about his talk,
And they're off!
- Erin Masercola (@MasercolaWrites)May 8, 2016
Run for Sight raises money for the ASCRS Foundation
With 364 participants at the starting line at the 4th annual run in New Orleans, the ASCRS Foundation raised over $12,000, bringing their total from the past four years to $81,000.
Valeant Collaborating with Bausch + Lomb And IBM on an App for
- Ophthalmology Times (@OphthTimes)May 7, 2016
One of a kind cataract app coming soon
The collaborative app is meant to streamline the workflow of cataract surgeons. Pilot testing is expected to begin late 2016 and will be available on iPhones and iPads.
Cosmetic iris implants like NewColorIris & BrightOcular would *never* be approved in places w good regulation like US, UK or Australia
- Dr Daya Sharma (@DrDayaSharma)May 6, 2016
What is a different eye color worth?
Patients are travelling abroad to have procedures done, despite the lack of regulation and permanant consequences. It is the responsibility of the surgeon to fully explain the dangers to patients and encourage prompt removal. To read more,
Thanks
- MichaelJohnson (@mjohnsp)May 7, 2016
OWL encourages diversity within the ophthalmic community
OWL panel members presented a talk on diversity, explaining their desire to reach out not only to women, but to ophthalmic profressionals with a wide range of cultural and ethnic backgrounds.
We see you,
- Pascale (@PascaleCom)May 8, 2016
The developer of one booth had Mother’s Day in mind!
While some booths took advantage of the meeting occuring on Mother's Day by giving out roses to all the women, one booth allowed attendees to pose for a photo to celebrate the day.
Today at 5:15 p.m.: 34th ASCRS Film Festival Awards in Great Hall A&D:
- ASCRS (@ASCRStweets)May 9, 2016
Did you catch the ASCRS Film Awards?
Congrats to Shin Yamane, MD of Yokohama, Japan, the 2016 Grand Prize winner at the ASCRS Film Festival Awards! The video was titled: Transconjunctival Intrascleral IOL Fixation with Double-Needle Technique.
- Imprimis Pharma (@ImprimisPharma)May 5, 2016
Alternative to IV anesthetic may be found in sublingual form
The patent-pending melt, containing midazolam, ketamine, and ondansetron (IV Free MKO Melt, Imprimis) allows for consistent dosing which is gaining in popularity due to its ease of administration. The company says this formulation, which eliminates the need for intravenous sedation medication, can reduce the need for additional staff to assist with the procedure.
Cataract Surgery Olympics Dr. Malyugin
- Rob Melendez,MD,MBA (@DrRobMelendez)May 8, 2016
Get ready for this summer with the ASCRS Cataract Surgery Olympics
In honor of the 2016 Rio De Janeiro Summer Olympics, the ASCRS committee orchestrated a 90-minute symposium on managing complicated cataract cases. Moderator David F. Chang, MD, said the event is a "must-see" in which surgeons from 14 countries present their best video teaching cases in rapid fire succession.
The four Olympic events are:
- Cataract Pentathlon (best use of up to five surgical devices)
- Cataract Marathon (most challenging and agonizaingly difficult case)
- Cataract IOL Gymnastics (skill and creativity in managing IOL complications)
- Freestyle Cataract Surgery (anything that doesn't fit into the previous categories)
Ophthalmologists have had mixed feelings about the timing of the Olympic Games and the Zika virus.
Dr Doyle Stulting is now presenting Binkhorst Lecture "Predicting and Treating Corneal
- Dr Daya Sharma (@DrDayaSharma)May 7, 2016
- Dr Daya Sharma (@DrDayaSharma)
Binkhorst Lecture focuses on efforts to treat keratoconus, ectasia
Dr. Stulting said the constant dilemma surgeons face is classifying corneal topography maps. "Even the best of us have a hard time judging these images," he said. "But why is our risk system failing today? RSB is increasing, but FFKC is decreasing. Corneal thickness is also decreasing. The mean patient age is decreasing. We're still operating on young patients and the elimination of other risk factors are making age a much more relevant factor."
To read more about his lecture,
Don't miss the ever-popular "Pardon the Ophthalmology," starting today at 3 p.m. in Great Hall A&D:
- ASCRS (@ASCRStweets)May 7, 2016
“Pardon the Ophthalmology” session features Terry Kim, MD
Dr. Kim, also known as DJ Special K, was recently featured in an article about how he juggles DJing with his hectic schedule as a surgeon. To learn more,
Lumenis Presents Interim Safety, Efficacy Results of IPL with OPT for Treating Dry Eye at
- Ophthalmology Times (@OphthTimes)May 6, 2016
Lumenis presents data for new treatment for dry eye
Lumenis releases data from their clinical trial studying 40 patients receiving 3 treatments for dry eye caused by Meibomian Gland Dynsfunction (MGD). The study included examinations of tear break-up time, SPEED questionaire scores, and tear osmolarity.
Related:
Fast Track Marketing
- Fast-Track Marketing (@FTMarketing)May 11, 2016
The New Orleans fun didn't stop at the end of sessions!
Housing for the 2017 ASCRS•ASOA Symposium & Congress, May 5–9, is now open!
- ASCRS (@ASCRStweets)May 6, 2016
See you next year in Los Angeles!
Click here for
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Regeneron receives another CRL for its Eylea 8 mg
2
Topcon Healthcare seeks to advance company through acquisition and new investment
3
What if? Ophthalmology without OCT – Part 3
4
Throwback Series: From epidemic to innovation in corneal surgery
5
.png "Optometry Times"){kind=logo}
